Picture of Senzime AB (publ) logo

SEZI — Senzime AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Senzime Confirms Clinical Advantage Of Tetragraph System In US Study

July 3 (Reuters) - Senzime AB (publ)  SEZI.ST :
    * NEW US STUDY CONFIRMS THE CLINICAL ADVANTAGE OF THE
TETRAGRAPH
SYSTEM FOR INFANTS AND YOUNG CHILDREN

Source text for Eikon:  ID:nMFN4Ntm11 
Further company coverage:  SEZI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Senzime AB (publ)

See all news